Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination
Condition: SmallpoxInterventions: Biological: ACAM1000; Biological: vaccinia virus (calf lymph) smallpox vaccine: DryvaxSponsors: Sanofi; Sanofi Pasteur, a Sanofi CompanyTerminated - verified January 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2003 Category: Research Source Type: clinical trials